MYLAN PHARMACEUTICALS INC recalls Mycophenolate Mofetil for Injection USP
- Recalling company
- MYLAN PHARMACEUTICALS INC
- Product
- Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).
- Reason
- Presence of precipitate
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jul 2, 2026
- Reported
- Aug 5, 2026
- Distribution
- USA Nationwide
- Status
- Ongoing
- Quantity
- 5688 vials
- Lot / codes
- Lot #: 3241653, Exp 4/30/2027
- Company location
- Morgantown, WV
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0734-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0734-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.